As of April 16, 2025, Medios AG (ILM1.DE) has a market cap of $0.32 billion USD. According to our data, Medios AG is ranked No.6436 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.32 B |
-11.62%
|
Dec 30, 2024 | $0.37 B |
-19.67%
|
Dec 29, 2023 | $0.46 B |
-9.37%
|
Dec 30, 2022 | $0.50 B |
-54.95%
|
Dec 30, 2021 | $1.12 B |
3.88%
|
Dec 30, 2020 | $1.08 B |
41.67%
|
Dec 30, 2019 | $0.76 B |
95.56%
|
Dec 28, 2018 | $0.39 B |
-30.95%
|
Dec 29, 2017 | $0.56 B |
150.64%
|
Dec 30, 2016 | $0.22 B |
1,460.00%
|
Dec 30, 2015 | $14.41 M |
0.00%
|
Dec 30, 2014 | $14.41 M |
0.00%
|
Dec 30, 2013 | $14.41 M |
0.00%
|
Dec 28, 2012 | $14.41 M |
0.00%
|
Dec 30, 2011 | $14.41 M |
0.00%
|
Dec 30, 2010 | $14.41 M |
13.64%
|
Dec 30, 2009 | $12.69 M |
-63.33%
|
Dec 30, 2008 | $34.60 M |
-79.31%
|
Dec 28, 2007 | $0.17 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
Market Cap | = | ILM1.DE Stock Price | * | ILM1.DE Shares Outstanding |
= | $12.73 | * | 25.51 M | |
= | $0.32 B |